Cambridge Spin-out PharmEnable Raises £1.8 million for Drug Discovery Expansion £1.8m seed financing led by Cambridge Enterprise alongside angel investors and life science investment funds Using advanced medicinal chemistry and AI approaches to develop highly complex Read More
